Hubei Bafeng pharmaceutical & Chemical Co., Ltd., established in April 1997, mainly produces and operates amino acid API series, amino acid oral preparation series (oral solution, tablet, capsule and granule), amino acid oral liquid series, amino acid derivative series, D (DL) amino acid series, other amino acids, etc. at present, it is the domestic product of medical amino acids in China One of the industrialization bases. Adhering to the development strategy of "revitalizing the enterprise through science and technology", the company has established a postdoctoral scientific research workstation, Hubei amino acid technology center and postdoctoral industry base. It has long carried out "industry university research" cooperation with more than 10 domestic scientific research institutes such as Institute of Microbiology, Chinese Academy of Sciences and Wuhan University, with strong technical R & D capacity, Five technologies have won the first prize of scientific and technological progress of Hubei Province and the first prize of spark plan of Hubei Province, a total of eight major scientific and technological achievements of Hubei Province, and have successively undertaken more than 20 research topics such as the national and Hubei torch plan and scientific and technological breakthrough plan. Among them, the technology of amino acid acyl hydrolase resolution of mixed spin methionine, the construction and immobilization of glyA genetic engineering bacteria have won the national intellectual property invention patent certificate. The company has GMP certificate, more than 20 drug approval numbers, and has an annual production capacity of 3000 tons of amino acid API, 20 million pieces of amino acid oral liquid and 750 million pieces (pieces and bags) of amino acid preparations. The company has established a perfect international and domestic marketing network, and its API products are exported to more than 20 countries and regions.